RGBPP
Price:
$0.0032
Market Cap:
$3.15K
Regen BioPharma, Inc. is dedicated to advancing regenerative medicine solutions across the United States. The company's scientific endeavors involve identifying small molecules that modulate NR2F6, with the aim of either stimulating immune cells for cancer treatments or suppressing them for managing autoimmune conditions. Currently, its product pipeline and therapeutic approaches are in nascent developmental phases. Established in 2012, Regen BioPharma, Inc. operates from its headquarters in La Mesa, California.
Industry
Biotechnology
IPO Date
2016-04-20
Stock Exchange
OTC
Ticker
RGBPP
According to Regen BioPharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.19. This represents a change of -64.97% compared to the average of -0.54 of the last 4 quarters.
The mean historical PE Ratio of Regen BioPharma, Inc. over the last ten years is 0.20. The current -0.19 PE Ratio has changed -9629.33% with respect to the historical average. Over the past ten years (40 quarters), RGBPP's PE Ratio was at its highest in in the September 2022 quarter at 24.21. The PE Ratio was at its lowest in in the March 2023 quarter at -14.69.
Average
0.20
Median
-0.34
Minimum
-6.79
Maximum
6.87
Discovering the peaks and valleys of Regen BioPharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 140.46%
Maximum Annual PE Ratio = 6.87
Minimum Annual Increase = -8865.77%
Minimum Annual PE Ratio = -6.79
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.25 | -60.57% |
| 2024 | -0.63 | -110.14% |
| 2023 | 6.23 | -9.27% |
| 2022 | 6.87 | -201.28% |
| 2021 | -6.79 | -8865.77% |
| 2020 | 0.08 | -117.82% |
| 2019 | -0.43 | 140.46% |
| 2018 | -0.18 | -68.20% |
| 2017 | -0.57 | -75.73% |
| 2016 | -2.34 | -38.23% |
The current PE Ratio of Regen BioPharma, Inc. (RGBPP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.78
5-year avg
1.09
10-year avg
0.20
Regen BioPharma, Inc.’s PE Ratio is greater than Restart Life Sciences Corp. (-2.19), less than ReNeuron Group plc (-0.01), greater than Appili Therapeutics Inc. (-0.65), less than Ayala Pharmaceuticals, Inc. (-0.08), less than Algernon Pharmaceuticals Inc. (-0.08), greater than Zelira Therapeutics Limited (-1.60), greater than ProtoKinetix, Incorporated (-5.38), greater than Universal Ibogaine Inc. (-4.16), less than HAVN Life Sciences Inc. (-0.01), greater than RepliCel Life Sciences Inc. (-9.60),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.19 | $1.28M | |
| -0.01 | $62.89K | |
| -0.65 | $1.28M | |
| -0.08 | $25.71M | |
| -0.08 | $1.33M | |
| -1.60 | $4.16M | |
| -5.38 | $2.04M | |
| -4.16 | $7.40M | |
| -0.01 | $2.56K | |
| -9.60 | $7.00K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regen BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Regen BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Regen BioPharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Regen BioPharma, Inc. (RGBPP)?
What is the highest PE Ratio for Regen BioPharma, Inc. (RGBPP)?
What is the 3-year average PE Ratio for Regen BioPharma, Inc. (RGBPP)?
What is the 5-year average PE Ratio for Regen BioPharma, Inc. (RGBPP)?
How does the current PE Ratio for Regen BioPharma, Inc. (RGBPP) compare to its historical average?